Parkinson’s disease progression in the substantia nigra: location, location, location-Reference-Cited by-同舟云学术

Parkinson’s disease progression in the substantia nigra: location, location, location

Published:2020-09-01 Issue:9 Volume:143 Page:2628-2630
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Vaillancourt David E¹²³,Mitchell Trina²

Affiliation:

1. Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida, USA

2. Laboratory for Rehabilitation Neuroscience, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA

3. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA

Abstract

This scientific commentary refers to ‘Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease’, by Biondetti et al. (doi:10.1093/brain/awaa216

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/143/9/2628/36028605/awaa252.pdf

Reference13 articles.

1. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease;Biondetti;Brain,2020

2. Progression marker of Parkinson's disease: a 4-year multi-site imaging study;Burciu;Brain,2017

3. Age-specific progression of nigrostriatal dysfunction in Parkinson's disease;de la Fuente-Fernandez;Ann Neurol,2011

4. Ageing and Parkinson's disease: substantia nigra regional selectivity;Fearnley;Brain,1991

5. Diffusion magnetic resonance imaging-derived free water detects neurodegenerative pattern induced by interferon-gamma;Febo;Brain Struct Funct,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introducing a Possible Proteomic and Genomic Biomarker Panel Related to Methanol Poisoning: A Review;Journal of Cellular and Molecular Anesthesia;2024-04-02

2. Anti-Inflammatory Effects of Dipeptidyl Peptidase-4 Inhibitors and Their Therapeutic Application for Parkinson's Disease;Drug Targets and Therapeutics;2024-03-31

3. Restoration of MPTP-induced dopamine and tyrosine hydroxylase depletion in the mouse brain through ethanol and nicotine;2024-03-28

4. Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease;Neuroscience Letters;2024-01

5. Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?;Current Neuropharmacology;2023-08-01